Research map: Baseline 18F-FDG PET/CT metabolic parameters and systemic inflammatory markers in advanced NSCLC treated with first-line immunotherapy: an exploratory retrospective analysis

Back to the article

Papers in this map

  1. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer · Martin Reck · 2016 · 10309 citations · Cited by this paper
  2. Contrast-enhanced ultrasound-guided biopsy and perfusion monitoring for bladder involvement in relapsed multiple myeloma: a case report · 2026 · Related
  3. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer · H. Borghaei · 2015 · 9564 citations · Cited by this paper
  4. Ferroptosis in multiple myeloma: molecular mechanisms and therapeutic opportunities · 2026 · Related
  5. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer · Julie Renee Brahmer · 2015 · 8636 citations · Cited by this paper
  6. Adaptive dosing of immunotherapy plus anti-angiogenic therapy in a nonagenarian with hepatocellular carcinoma: a case report with 10-year survival · 2026 · Related
  7. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial · Roy S. Herbst · 2015 · 6592 citations · Cited by this paper
  8. Predictors and prevalence of lateral supraclavicular lymph node metastases on [18F]FDG PET/CT in patients with locally advanced, or multifocal invasive ductal carcinoma of breast: potential impact on adjuvant radiotherapy targets · 2026 · Related
  9. Molecular and cellular insights into T cell exhaustion · E. John Wherry · 2015 · 4756 citations · Cited by this paper
  10. Case Report: a hypermetabolic mediastinal mass (SUVmax 16.7) mimicking malignancy with spontaneous resolution: an inflammatory myofibroblastic proliferation and diagnostic pitfall · 2026 · Related
  11. Tumor mutational load predicts survival after immunotherapy across multiple cancer types · Robert M. Samstein · 2019 · 4457 citations · Cited by this paper
  12. Variations in histopathological and molecular subtypes between primary breast carcinoma and associated liver metastatic lesions · 2026 · Related
  13. Inflammation and Cancer: Triggers, Mechanisms, and Consequences · Florian R. Greten · 2019 · 3885 citations · Cited by this paper
  14. Concurrent icotinib and definitive radiotherapy followed by detection of an EGFR exon 20 insertion at disease progression in unresectable stage III EGFR S768I-mutant lung adenocarcinoma: a case report · 2026 · Related
  15. Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression · Chih‐Hao Chang · 2015 · 3398 citations · Cited by this paper
  16. Perioperative outcomes and prognostic determinants in adult spindle cell/sclerosing rhabdomyosarcoma: implications of treatment intensity, surgical margins, and molecular heterogeneity · 2026 · Related
  17. The tumor microenvironment · Nicole M. Anderson · 2020 · 2743 citations · Cited by this paper
  18. The combined compartmental maxillary resection: technique codification and preliminary multicenter series analysis · 2026 · Related
  19. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy · Răzvan Cristescu · 2018 · 2407 citations · Cited by this paper
  20. Enhancing multimodal survival prediction: tri-modal learning with clinical knowledge integration via state space models · 2026 · Related
  21. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation · Muhammad Zaeem Noman · 2014 · 2214 citations · Cited by this paper
  22. Non-small-cell lung cancers: a heterogeneous set of diseases · Zhao Chen · 2014 · 2070 citations · Cited by this paper
  23. Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature · Digant Gupta · 2010 · 1544 citations · Cited by this paper
  24. The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer · Donald C. McMillan · 2012 · 1437 citations · Cited by this paper
  25. The lung microenvironment: an important regulator of tumour growth and metastasis · Nasser Khaled Altorki · 2018 · 1226 citations · Cited by this paper
  26. High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types · Daniel James McGrail · 2021 · 1094 citations · Cited by this paper
  27. Metastatic sites and survival in lung cancer · Matias Riihimäki · 2014 · 926 citations · Cited by this paper
  28. Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer · Valsamo Anagnostou · 2018 · 325 citations · Cited by this paper
  29. Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers · Christopher J. D. Wallis · 2019 · 311 citations · Cited by this paper
  30. Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis · Hyung‐Jun Im · 2014 · 250 citations · Cited by this paper
  31. Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors · Romain‐David Seban · 2019 · 139 citations · Cited by this paper
  32. Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics · Romain‐David Seban · 2019 · 135 citations · Cited by this paper
  33. The Predictive Value of Pre-treatment Inflammatory Markers in Advanced Non-small-Cell Lung Cancer · G. Kasymjanova · 2010 · 127 citations · Cited by this paper
  34. FDG PET Metabolic Tumor Volume Segmentation and Pathologic Volume of Primary Human Solid Tumors · Praveen Sridhar · 2014 · 95 citations · Cited by this paper
  35. Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors · Shiva Shrotriya · 2018 · 95 citations · Cited by this paper
  36. Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism · Abhilasha Sharma · 2022 · 83 citations · Cited by this paper
  37. Metabolic Signature of Warburg Effect in Cancer: An Effective and Obligatory Interplay between Nutrient Transporters and Catabolic/Anabolic Pathways to Promote Tumor Growth · Marilyn Mathew · 2024 · 78 citations · Cited by this paper
  38. Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non–Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy · Akshima Sharma · 2017 · 71 citations · Cited by this paper
  39. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers · Caterina Gulìa · 2020 · 62 citations · Cited by this paper

Source: OpenAlex (CC0)